Electronic Resource
Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
| العنوان: | Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature |
|---|---|
| المؤلفون: | Fernández de las Peñas, César, Navarro Santana, Marcos José, Gómez Mayordomo, Víctor, Cuadrado Pérez, María De La Luz, García Azorín, David, Arendt Nielsen, Lars, Plaza Manzano, Gustavo |
| بيانات النشر: | Wiley 2024-06-10T16:31:34Z 2024-06-10T16:31:34Z 2021-07-30 |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | Headache is identified as a common post-COVID sequela experienced by COVID-19 survivors. The aim of this pooled analysis was to synthesize the prevalence of post-COVID headache in hospitalized and non-hospitalized patients recovering from SARS-CoV-2 infection. Methods MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers, were searched up to 31 May 2021. Studies or preprints providing data on post-COVID headache were included. The methodological quality of the studies was assessed using the Newcastle-Ottawa Scale. Random effects models were used for meta-analytical pooled prevalence of post-COVID headache. Data synthesis was categorized at hospital admission/symptoms' onset, and at 30, 60, 90, and ≥180 days afterwards. Results From 9573 studies identified, 28 peer-reviewed studies and 7 preprints were included. The sample was 28,438 COVID-19 survivors (12,307 females; mean age: 46.6, SD: 17.45 years). The methodological quality was high in 45% of the studies. The overall prevalence of post-COVID headache was 47.1% (95% CI 35.8–58.6) at onset or hospital admission, 10.2% (95% CI 5.4–18.5) at 30 days, 16.5% (95% CI 5.6–39.7) at 60 days, 10.6% (95% CI 4.7–22.3) at 90 days, and 8.4% (95% CI 4.6–14.8) at ≥180 days after onset/hospital discharge. Headache as a symptom at the acute phase was more prevalent in non-hospitalized (57.97%) than in hospitalized (31.11%) patients. Time trend analysis showed a decreased prevalence from the acute symptoms’ onset to all post-COVID follow-up periods which was maintained afterwards. Conclusion This meta-analysis found that the prevalence of post-COVID headache ranged from 8% to 15% during the first 6 months after SARS-CoV-2 infection. Novo Nordisk Foundation (0067235) Sección Deptal. de Radiología, Rehabilitación y Fisioterapia (Enfermería) Fac. de Enfermería, Fisioterapia y Podología TRUE pub |
| مصطلحات الفهرس: | 615.8, COVID-19, Headache, post-COVID, Fisioterapia (Enfermería, Fisioterapia y Podología), 3213.11 Fisioterapia, journal article, VoR |
| URL: | Fernández‐de‐las‐Peñas, C., Navarro‐Santana, M., Gómez‐Mayordomo, V., Cuadrado, M. L., García‐Azorín, D., Arendt‐Nielsen, L., & Plaza‐Manzano, G. (2021). Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature. European journal of neurology, 28(11), 3820-3825. |
| الاتاحة: | Open access content. Open access content Attribution-NonCommercial 4.0 International http://creativecommons.org/licenses/by-nc/4.0 open access |
| ملاحظة: | application/pdf 1468-1331 English |
| Other Numbers: | ESRCM oai:docta.ucm.es:20.500.14352/104822 1351-5101 1468-1331 10.1111/ene.15040 1449910721 |
| المصدر المساهم: | REPOSITORIO E-PRINTS UNIVERSIDAD COMPLU From OAIster®, provided by the OCLC Cooperative. |
| رقم الانضمام: | edsoai.on1449910721 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |